Browse studies

Find your next paid study

639 recruiting studies matching your filters

Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.

Bladder Spasms

Estimated

~$10 – $6,250

Mayo ClinicNCT05806996

Carolina Senior: UNC Registry for Older Cancer Patients

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering inform…

Chronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more

Estimated

~$10 – $750

UNC Lineberger Comprehensive Cancer CenterNCT01137825

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain …

CancerImmunotherapyAdvanced Solid Tumors Cancer+12 more

Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R +…

Opioid UseStimulant UseDepression and Anxiety Symptoms

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07673380

Observational

Neurologic Bone Marrow Derived Stem Cell Treatment Study

This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3…

Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more

Estimated

~$10 – $7,500

MD Stem CellsNCT02795052

Phase 2

Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases

This is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TB…

Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more

Estimated

~$10 – $6,250

Investigations of Individuals With MEHMO Syndrome or eIF2-Pathway Related Conditions

This observational natural history study will follow individuals with MEHMO (Mental disability, Epileptic seizure, Hypopituitarism/Hypogenitalism, Microcephaly…

Intellectual DisabilityEpilepsyHypogonadisms+3 more

Estimated

~$10 – $675

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT06019182

Phase 1

A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Subjects With Advanced Solid Tumors

The goal of this study is to assess the safety and tolerability of Mocertatug Rezetecan . The study will also see how the levels of Mo-Rez change over time at …

Solid TumorsNeoplasms

Estimated

~$10 – $7,500

GlaxoSmithKlineNCT06431594

Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples From Patients With Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members

This study will collect biological samples for use in research experiments aimed at better understanding the clinical features of certain diseases. The specime…

NeoplasmsHematologic NeoplasmsHealthy Volunteers

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT00071045

Phase 2

An Open-Label, Multicenter, Long-term Treatment Extension Study in Subjects Who Have Completed a Prior GlaxoSmithKline/TESARO-Sponsored Niraparib Study and Are Judged by the Investigator to Benefit From Continued Treatment With Niraparib

This is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants …

Ovarian NeoplasmsBreast Neoplasms

Estimated

~$10 – $7,500

GlaxoSmithKlineNCT04641247

Phase 1

A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4175408, an Antibody Drug Conjugate Targeting Protein Tyrosine Kinase 7-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors

The purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, this study will evalua…

Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07046923

Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center Cohort

The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answe…

Malignant Neoplasms

Estimated

~$10 – $750

Icahn School of Medicine at Mount SinaiNCT05394428